Related Experiment Video

Updated: Mar 15, 2026

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.3K

Bone morphogenetic protein 6-a possible new player in pathophysiology of heart failure

Joanna Banach1, Wojciech Gilewski1, Artur Słomka2

  • 1IInd Chair and Clinic of Cardiology, University Hospital nr 2, Collegium Medicum of Nicolaus Copernicus University in Bydgoszcz, Bydgoszcz, Poland.

Clinical and Experimental Pharmacology & Physiology
|September 6, 2016
PubMed

Insights

Bone morphogenetic protein 6 (BMP6) plasma levels are elevated in chronic heart failure (CHF) patients, correlating with disease severity and exacerbation signs. However, BMP6 did not predict mortality or hospitalisation in this cohort.

Area of Science:

  • Biochemistry
  • Cardiology
  • Molecular Biology

Background:

  • Bone morphogenetic protein (BMP) signaling is implicated in cardiovascular diseases.
  • This study investigates the diagnostic and prognostic utility of plasma BMP6 in chronic heart failure (CHF).

Discussion:

  • Elevated BMP6 levels in CHF patients correlate with disease severity and indicators of exacerbation, such as pulmonary congestion and peripheral edema.
  • BMP6 may play a role in the pathophysiology of systolic CHF.
  • Despite its association with disease severity, BMP6 plasma concentration did not serve as a predictor for all-cause mortality or CHF hospitalizations.

Key Insights:

  • BMP6 plasma levels are significantly increased in patients with chronic heart failure.
  • Higher BMP6 concentrations are observed in patients with more advanced disease and signs of fluid overload.
  • BMP6 is related to disease severity and exacerbation in CHF.

Outlook:

  • Further research is warranted to elucidate the precise role of BMP6 in CHF pathophysiology.
  • Investigating therapeutic strategies targeting BMP6 signaling could be a future direction.
  • Exploring BMP6 in different cardiovascular conditions may reveal broader implications.

Keywords:
aldosteronebone morphogenetic protein 6diagnosisheart failurepathophysiologyprognosis

More Related Videos

Light-sheet Fluorescence Microscopy to Capture 4-Dimensional Images of the Effects of Modulating Shear Stress on the Developing Zebrafish Heart06:51

Light-sheet Fluorescence Microscopy to Capture 4-Dimensional Images of the Effects of Modulating Shear Stress on the Developing Zebrafish Heart

Published on: August 10, 2018

8.9K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.7K

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
618
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.1K
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
436
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
849